ZM Stock Cash Flow Statements
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Quarterly Cash Flow Statements
Quarterly
|
Annual
Unit: USD | 2024-01-31 | 2023-10-31 | 2023-07-31 | 2023-04-30 | 2023-01-31 | 2022-10-31 | 2022-07-31 | 2022-04-30 | 2022-01-31 | 2021-10-31 | 2021-07-31 | 2021-04-30 | 2021-01-31 | 2020-10-31 | 2020-07-31 | 2020-04-30 | 2020-01-31 | 2019-10-31 | 2019-07-31 | 2019-04-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||
net income | 298,832,000 | 141,212,000 | 181,974,000 | 15,444,000 | -104,050,000 | 48,353,000 | 45,750,000 | 113,658,000 | 490,641,000 | 340,383,000 | 317,084,000 | 227,531,000 | 260,610,000 | 198,642,000 | 185,989,000 | 27,075,000 | 15,339,000 | 2,211,000 | 5,541,000 | 2,214,000 |
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||
stock-based compensation expense | 254,373,000 | 258,934,000 | 261,509,000 | 282,345,000 | 518,059,000 | 302,815,000 | 255,515,000 | 209,363,000 | 161,375,000 | 114,801,000 | 102,142,000 | 98,969,000 | 96,261,000 | 93,925,000 | 56,855,000 | 28,777,000 | 26,577,000 | 21,795,000 | 18,075,000 | 6,662,000 |
deferred income taxes | -136,735,000 | 6,081,000 | -7,536,000 | 21,511,000 | ||||||||||||||||
amortization of deferred contract acquisition costs | 66,793,000 | 65,164,000 | 65,514,000 | 73,230,000 | 72,742,000 | 67,124,000 | 62,722,000 | 56,780,000 | 51,592,000 | 46,299,000 | 41,626,000 | 37,766,000 | 33,025,000 | 30,500,000 | 24,494,000 | 16,287,000 | 11,162,000 | 9,913,000 | 8,607,000 | 7,419,000 |
(gains) losses on strategic investments | -101,296,000 | 25,471,000 | -31,670,000 | -2,275,000 | ||||||||||||||||
depreciation and amortization | 27,272,000 | 26,977,000 | 26,126,000 | 24,076,000 | 24,400,000 | 21,766,000 | 20,875,000 | 15,280,000 | 12,913,000 | 12,584,000 | 12,028,000 | 10,663,000 | 9,456,000 | 7,587,000 | 6,475,000 | 5,339,000 | 4,860,000 | 4,415,000 | 3,850,000 | 3,324,000 |
benefit from accounts receivable allowances | 6,182,000 | 6,858,000 | 6,771,000 | 15,433,000 | 10,705,000 | 12,853,000 | 13,630,000 | 13,097,000 | 13,265,000 | 8,890,000 | 10,537,000 | 4,055,000 | 11,789,000 | 5,259,000 | 11,091,000 | 3,868,000 | 2,394,000 | 1,283,000 | 1,865,000 | 828,000 |
unrealized foreign exchange losses | -11,022,000 | 18,598,000 | 1,367,000 | 3,316,000 | ||||||||||||||||
non-cash operating lease cost | 5,225,000 | 5,184,000 | 5,276,000 | 5,381,000 | 11,984,000 | 5,882,000 | 5,616,000 | 5,451,000 | 5,256,000 | 4,498,000 | 4,359,000 | 4,274,000 | 3,705,000 | 2,585,000 | 2,349,000 | 2,248,000 | ||||
amortization of discount/premium on marketable securities | -17,463,000 | -15,293,000 | -11,249,000 | -6,765,000 | -2,950,000 | |||||||||||||||
other | -2,419,000 | -1,836,000 | 2,056,000 | -5,471,000 | -27,015,000 | 22,623,000 | 6,575,000 | 12,730,000 | 2,464,000 | 1,863,000 | -5,602,000 | 5,866,000 | 105,000 | 1,689,000 | 911,000 | 1,117,000 | 509,000 | -1,063,000 | -771,000 | 257,000 |
changes in operating assets and liabilities: | ||||||||||||||||||||
accounts receivable | -18,723,000 | 58,362,000 | 42,732,000 | -29,101,000 | 6,175,000 | -112,122,000 | -42,293,000 | -83,605,000 | -50,642,000 | 8,718,000 | -41,594,000 | -75,665,000 | -28,922,000 | 6,809,000 | -54,425,000 | -142,501,000 | -27,829,000 | -1,525,000 | -19,258,000 | -16,103,000 |
prepaid expenses and other assets | 53,208,000 | -40,567,000 | -77,229,000 | -6,659,000 | 145,655,000 | -27,102,000 | -109,384,000 | -27,235,000 | -83,936,000 | -14,628,000 | -27,395,000 | -29,975,000 | -20,263,000 | 5,471,000 | -4,649,000 | -49,080,000 | -2,366,000 | 1,158,000 | -14,980,000 | -8,617,000 |
deferred contract acquisition costs | -68,303,000 | -53,427,000 | -46,589,000 | -46,338,000 | -80,807,000 | -60,817,000 | -91,315,000 | -65,690,000 | -82,066,000 | -62,708,000 | -54,784,000 | -47,813,000 | -40,774,000 | -52,504,000 | -88,936,000 | -124,854,000 | -21,890,000 | -17,124,000 | -19,266,000 | -14,434,000 |
accounts payable | -2,158,000 | -7,257,000 | 3,118,000 | 1,881,000 | -12,950,000 | 8,120,000 | 5,288,000 | 11,153,000 | -14,280,000 | -31,898,000 | 42,368,000 | 1,592,000 | -5,292,000 | -2,098,000 | 9,115,000 | 1,756,000 | -912,000 | 1,665,000 | -7,156,000 | 4,373,000 |
accrued expenses and other liabilities | 51,989,000 | 58,936,000 | -83,591,000 | 24,640,000 | -95,861,000 | 52,129,000 | -13,974,000 | 78,236,000 | -70,545,000 | 78,105,000 | 5,153,000 | 88,656,000 | 47,735,000 | 1,853,000 | 34,744,000 | 167,322,000 | -2,306,000 | 18,562,000 | 22,700,000 | 12,223,000 |
deferred revenue | -48,637,000 | -54,414,000 | 2,992,000 | 53,340,000 | -46,924,000 | -46,225,000 | 67,576,000 | 152,974,000 | -10,626,000 | 7,877,000 | 85,740,000 | 210,896,000 | 32,124,000 | 114,451,000 | 196,287,000 | 322,862,000 | 29,707,000 | 20,345,000 | 32,677,000 | 23,557,000 |
operating lease liabilities | -5,893,000 | -5,830,000 | -5,600,000 | -5,501,000 | -6,171,000 | -6,318,000 | -5,301,000 | -6,049,000 | -4,564,000 | -4,716,000 | -4,211,000 | -3,513,000 | -2,701,000 | -2,699,000 | -1,266,000 | 287,000 | -736,000 | -1,429,000 | -2,295,000 | -1,000,000 |
net cash from operating activities | 351,225,000 | 493,153,000 | 335,971,000 | 418,487,000 | 211,588,000 | 295,314,000 | 257,209,000 | 526,151,000 | 209,396,000 | 394,556,000 | 468,012,000 | 533,302,000 | 399,396,000 | 411,470,000 | 401,346,000 | 258,965,000 | 36,554,000 | 61,930,000 | 31,172,000 | 22,236,000 |
cash flows from investing activities: | ||||||||||||||||||||
purchases of marketable securities | -1,120,371,000 | -1,137,431,000 | -1,057,936,000 | -768,230,000 | -922,072,000 | -350,196,000 | -965,191,000 | -611,662,000 | -988,436,000 | -1,351,726,000 | -669,136,000 | -1,425,451,000 | -1,040,361,000 | -531,227,000 | -277,336,000 | -207,546,000 | -171,121,000 | -150,620,000 | -455,175,000 | -23,312,000 |
maturities of marketable securities | 773,341,000 | 814,958,000 | 983,434,000 | 559,686,000 | 697,321,000 | 831,199,000 | 697,349,000 | 609,327,000 | 685,498,000 | 255,639,000 | 500,859,000 | 291,047,000 | 174,188,000 | 119,269,000 | 150,324,000 | 137,014,000 | 179,414,000 | 113,200,000 | 22,050,000 | 28,890,000 |
sales of marketable securities | 15,285,000 | 162,013,000 | 0 | 0 | 10,284,000 | 26,613,000 | ||||||||||||||
purchases of property and equipment | -18,540,000 | -39,987,000 | -46,600,000 | -21,826,000 | -28,258,000 | -22,698,000 | -27,832,000 | -25,038,000 | -20,774,000 | -19,767,000 | -12,975,000 | -79,074,000 | -21,455,000 | -23,264,000 | -27,981,000 | -7,272,000 | -9,952,000 | -7,195,000 | -14,040,000 | -6,897,000 |
purchases of strategic investments | -17,727,000 | -1,800,000 | 0 | -51,000,000 | -4,000,000 | -3,500,000 | -49,800,000 | -11,750,000 | -178,800,000 | -39,449,000 | ||||||||||
proceeds from strategic investments | 62,823,000 | 0 | ||||||||||||||||||
cash paid for acquisition, net of cash acquired | 0 | 0 | -5,502,000 | -199,416,000 | 0 | 0 | -1,380,000 | 0 | 0 | 0 | ||||||||||
purchases of intangible assets | -700,000 | -7,357,000 | 0 | -3,211,000 | ||||||||||||||||
net cash from investing activities | -319,283,000 | -364,260,000 | -19,360,000 | -480,786,000 | -257,709,000 | 447,748,000 | -466,027,000 | -42,334,000 | -491,999,000 | -1,002,916,000 | -144,204,000 | -1,219,978,000 | -889,043,000 | -437,816,000 | -172,527,000 | -63,034,000 | -3,369,000 | -47,615,000 | -447,165,000 | -1,319,000 |
cash flows from financing activities: | ||||||||||||||||||||
cash paid for repurchases of common stock | -9,225,000 | -564,832,000 | -293,534,000 | -132,412,000 | ||||||||||||||||
proceeds from issuance of common stock for employee stock purchase plan | 21,584,000 | 0 | 19,105,000 | 0 | 21,485,000 | 0 | 17,673,000 | 0 | ||||||||||||
proceeds from exercise of stock options | 1,859,000 | 650,000 | 3,418,000 | 4,268,000 | 1,762,000 | 1,750,000 | 1,810,000 | 3,255,000 | 3,023,000 | 4,653,000 | 3,368,000 | |||||||||
proceeds from employee equity transactions (remitted) to be remitted to employees and tax authorities | 791,000 | 3,216,000 | -11,662,000 | -9,984,000 | ||||||||||||||||
net cash from financing activities | 24,234,000 | -5,506,000 | 34,439,000 | 7,019,000 | 11,745,000 | -559,866,000 | -255,578,000 | -133,243,000 | 13,183,000 | -44,219,000 | 71,383,000 | -6,279,000 | 1,754,035,000 | 23,600,000 | 44,516,000 | 228,126,000 | 19,067,000 | 51,485,000 | -114,000 | 545,252,000 |
effect of exchange rate changes on cash, cash equivalents, and restricted cash | 11,077,000 | -17,492,000 | -1,228,000 | -2,553,000 | 28,531,000 | -20,528,000 | -6,686,000 | -9,425,000 | ||||||||||||
net increase in cash, cash equivalents, and restricted cash | 67,253,000 | 105,895,000 | 349,822,000 | -57,833,000 | -5,845,000 | 341,149,000 | -269,420,000 | -652,579,000 | 395,191,000 | -692,955,000 | 1,264,388,000 | -2,746,000 | 273,335,000 | 424,057,000 | 52,252,000 | 65,800,000 | -416,107,000 | 566,169,000 | ||
cash, cash equivalents, and restricted cash—beginning of year | ||||||||||||||||||||
cash, cash equivalents, and restricted cash—end of year | ||||||||||||||||||||
cash, cash equivalents, and restricted cash – beginning of period | 0 | 0 | 1,100,243,000 | 0 | 0 | 1,073,353,000 | 0 | 0 | 2,293,116,000 | 0 | 0 | 334,082,000 | 0 | 0 | 65,968,000 | |||||
cash, cash equivalents, and restricted cash – end of period | 105,895,000 | 349,822,000 | 1,042,410,000 | 162,668,000 | -471,082,000 | 1,414,502,000 | -652,579,000 | 395,191,000 | 1,600,161,000 | -2,746,000 | 273,335,000 | 758,139,000 | 65,800,000 | -416,107,000 | 632,137,000 | |||||
reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above: | ||||||||||||||||||||
cash and cash equivalents | 112,789,000 | 350,575,000 | 1,029,546,000 | 158,731,000 | -469,862,000 | 1,407,305,000 | -608,935,000 | 374,100,000 | 1,557,270,000 | 16,988,000 | -415,907,000 | 629,793,000 | ||||||||
restricted cash, current included in prepaid expenses and other current assets | -6,884,000 | -754,000 | 12,610,000 | 3,960,000 | -1,215,000 | 6,923,000 | -43,144,000 | 22,537,000 | 40,648,000 | 48,547,000 | -100,000 | 200,000 | ||||||||
restricted cash, noncurrent included in other assets, noncurrent | -10,000 | 1,000 | 254,000 | -23,000 | -5,000 | 274,000 | -500,000 | -1,446,000 | 2,243,000 | |||||||||||
total cash, cash equivalents, and restricted cash | 105,895,000 | 349,822,000 | 1,042,410,000 | 162,668,000 | -471,082,000 | 1,414,502,000 | -652,579,000 | 395,191,000 | 1,600,161,000 | 65,800,000 | -416,107,000 | 632,137,000 | ||||||||
proceeds from employee equity transactions to be remitted (remitted) to employees and tax authorities | -1,492,000 | 2,751,000 | ||||||||||||||||||
losses (gains) on strategic investments | -40,443,000 | 6,898,000 | ||||||||||||||||||
charitable donation of common stock | 0 | 0 | 22,312,000 | 1,000,000 | ||||||||||||||||
proceeds from follow-on public offering, net of underwriting discounts and commissions and other offering costs | ||||||||||||||||||||
amortization on marketable securities | 1,217,000 | 3,604,000 | 5,770,000 | 6,909,000 | ||||||||||||||||
net decrease in cash, cash equivalents, and restricted cash | ||||||||||||||||||||
losses on strategic investments | 36,404,000 | |||||||||||||||||||
proceeds from employee equity transactions remitted to employees and tax authorities | -4,086,000 | |||||||||||||||||||
income tax benefit from release of valuation allowance | ||||||||||||||||||||
gains on strategic investments | 110,736,000 | -122,421,000 | ||||||||||||||||||
purchase of intangible assets | -2,891,000 | -1,332,000 | -162,000 | |||||||||||||||||
purchase of equity investment | 0 | 0 | 0 | -8,000,000 | 0 | |||||||||||||||
purchase of convertible promissory note | -6,500,000 | 0 | 0 | 0 | -5,000,000 | |||||||||||||||
proceeds from issuance of convertible promissory notes and derivatives | ||||||||||||||||||||
sales of property and equipment | ||||||||||||||||||||
loans to employees | ||||||||||||||||||||
repurchase of convertible preferred stock | ||||||||||||||||||||
cash, cash equivalents, and restricted cash—beginning of period | ||||||||||||||||||||
cash, cash equivalents, and restricted cash—end of period | ||||||||||||||||||||
reconciliation of cash, cash equivalents, and restricted cash within the condensed consolidated balance sheets to the amounts shown in the statements of cash flows above: |